Literature DB >> 33730208

Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.

Mirjam C Hegeman1, Jolanda A Schoemaker-Delsing1, Jacqueline T M Luttikholt1, Harald E Vonkeman2,3.   

Abstract

Rheumatoid arthritis (RA) patients often report lacking information on medication side effects. The aims of this study were to observe how rheumatology healthcare providers deliver medication information and to determine in which specific domains information is missing. First, 12 single-blinded structured observations were performed during regular RA patient consultations. The observers noted whether and how medication and medication side effects were discussed. Second, 100 RA patients were asked to fill out an adaptation of the Satisfaction with Information about Medicines Scale (SIMS). Medication was discussed during all observed consultations. With new medication, its purpose and mode of action were explained in all cases, but possible side effects in only 33%. Overall, medication side effects were discussed in 58% of consultations. Most information delivery was verbal (92%). Response rate to the questionnaire was 61%. Overall satisfaction with medication education was mean 7.3 (± 1.9) (NRS 0-10) with a comparable high SIMS total satisfaction sum score of mean 12.3 (± 4.4). At subscale score levels, 89% were satisfied with the amount of information on the action and usage of medication, but only 47% with the information on the potential problems of medication. RA patients express overall high satisfaction with their medication education but there is still an unmet need for information on potential risks and side effects. Using the SIMS questionnaire in daily clinical practice may help focus medication education to the needs of the individual patient.

Entities:  

Keywords:  Medication education; Medication side effects; Patient perspectives; Rheumatoid arthritis; Shared decision-making

Year:  2021        PMID: 33730208     DOI: 10.1007/s00296-021-04815-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

Review 1.  Novel treatment strategies in rheumatoid arthritis.

Authors:  Gerd R Burmester; Janet E Pope
Journal:  Lancet       Date:  2017-06-10       Impact factor: 79.321

Review 2.  Rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Iain B McInnes
Journal:  Lancet       Date:  2016-05-03       Impact factor: 79.321

Review 3.  EULAR recommendations for patient education for people with inflammatory arthritis.

Authors:  Heidi A Zangi; Mwidimi Ndosi; Jo Adams; Lena Andersen; Christina Bode; Carina Boström; Yvonne van Eijk-Hustings; Laure Gossec; Jana Korandová; Gabriel Mendes; Karin Niedermann; Jette Primdahl; Michaela Stoffer; Marieke Voshaar; Astrid van Tubergen
Journal:  Ann Rheum Dis       Date:  2015-03-03       Impact factor: 19.103

4.  The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research.

Authors:  R Horne; M Hankins; R Jenkins
Journal:  Qual Health Care       Date:  2001-09

5.  Psychometric properties of a German version of the "Satisfaction with Information about Medicines Scale" (SIMS-D).

Authors:  Cornelia Mahler; Susanne Jank; Katja Hermann; Rob Horne; Sabine Ludt; Walter E Haefeli; Joachim Szecsenyi
Journal:  Value Health       Date:  2009-07-29       Impact factor: 5.725

Review 6.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Rheumatol       Date:  2015-11-06       Impact factor: 10.995

7.  Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry.

Authors:  Laura M M Steunebrink; Harald E Vonkeman; Peter M ten Klooster; Monique Hoekstra; Piet L C M van Riel; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2016-02-06       Impact factor: 2.980

8.  Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis.

Authors:  Claire Immediato Daien; Charlotte Hua; Bernard Combe; Robert Landewe
Journal:  RMD Open       Date:  2017-01-05

9.  Radiographic progression in early rheumatoid arthritis patients following initial combination versus step-up treat-to-target therapy in daily clinical practice: results from the DREAM registry.

Authors:  Laura M M Steunebrink; Letty G A Versteeg; Harald E Vonkeman; Peter M Ten Klooster; Monique Hoekstra; Mart A F J van de Laar
Journal:  BMC Rheumatol       Date:  2018-01-17

Review 10.  Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention.

Authors:  M A Quinn; P Emery
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.